Search Results 1251-1260 of 20081 for Hepatitis C

1. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

   Hepatitis C virus (HCV) positive subjects with chronic hepatitis C, or subjects with an active hepatitis C infection requiring anti-viral medication (at ...

2. Buprenorphine (intradermal route) - Side effects & uses - Mayo Clinic

   Hepatitis B or C, history of or; Hypokalemia (low potassium in the blood) or; Hypomagnesemia (low magnesium in the blood), severe or; Hypothyroidism (an ...

3. Publications - Erik C. Thorland, Ph.D. - Mayo Clinic

   Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical ...

4. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

   active Hepatitis B or Hepatitis C. Antiviral prophylaxis for chronic Hepatitis B virus infection may be used at the discretion of the investigator.

5. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

6. A Study Of The Effectiveness And Safety Of Vedolizumab Compared To Adalimumab For Participants With Ulcerative Colitis - Mayo Clinic

   Has chronic hepatitis B virus (HBV) infection* or chronic hepatitis C virus (HCV) infection (* HBV immune participants, ie, being hepatitis B surface ...

7. Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   ... hepatitis C, autoimmune disorders (eg, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis), drug-induced hepatotoxicity ...

8. Fosamprenavir (oral route) - Side effects & dosage - Mayo Clinic

   May make these conditions worse. Liver disease (including hepatitis B or C) or; Sulfa allergy, history of—Use with caution. May cause side effects to become ...

9. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

   ... c\]), or T3 to T4 due to multiple lung nodules that are too extensive or ... hepatitis C infection (participants with hepatitis C that achieve a ...

10. Losing weight as a couple - Mayo Clinic News Network

    Irizarry Alvarado says. "We are really living." Mayo Clinic Q and A: Understanding hepatitis C · Former Army ...